focus -WSS

focus

author：knowledge 2025-08-31 16:44:23 - browse：99

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Florida health officials providing scant details on measles cases

WSS

Why Talkspace is targeting Medicare, a tricky market

Readout Newsletter: BridgeBio, Akero, and human embryo models

Rock icon Freddie Mercury pre

Why Talkspace is targeting Medicare, a tricky market

Special counsel alerts court to Trump’s social media post

California Joshua trees severely burned in massive wildfire

explore

focus

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

IVF doctors demand details after CooperSurgical lawsuit

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Rock icon Freddie Mercury pre

Medical leaders decry Supreme Court decision on affirmative action

The public health thinking behind the CDC’s new Covid guidance

Cancer drug shortages should be causing more outrage

Russian court extends detention of American musician

How to save PrEP access — and even expand it

Prosecutors seek bail revocation for FTX founder Sam Bankman

focus

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

$1 billion proposal to grow Boston, Massachusetts biotech

A new approach to psychiatric drug development

Florida health officials providing scant details on measles cases

Slain Parkland victim's father speaks out following reenactment

entertainment

focus

knowledge

hotspot